Finance

Lists
600329:SHA
Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd
CNÂ¥42.51
-0.93%
(-0.40) 1D
Nov 4, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600329...
Open
CNÂ¥43.01
High
CNÂ¥43.40
Low
CNÂ¥42.46
Mkt. cap
27.95B
Avg. vol.
4.26M
Volume
5.68M
Dividend
11.27%
Quarterly dividend
CNÂ¥1.20
Ex-dividend date
Jul 10, 2026
P/E ratio
36.59
52-wk high
CNÂ¥50.95
52-wk low
CNÂ¥33.83
EPS
CNÂ¥1.16
Shares outstanding
568.87M
No. of employees
4K
Open
CNÂ¥43.01
High
CNÂ¥43.40
Low
CNÂ¥42.46
Mkt. cap
27.95B
Avg. vol.
4.26M
Volume
5.68M
Dividend
11.27%
Quarterly dividend
CNÂ¥1.20
Ex-dividend date
Jul 10, 2026
P/E ratio
36.59
52-wk high
CNÂ¥50.95
52-wk low
CNÂ¥33.83
EPS
CNÂ¥1.16
Shares outstanding
568.87M
No. of employees
4K
News stories
From web sources and news partners
About Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd
CEO-
Employees3.89K
Founded1915
Headquarters-
SectorPharmaceutical industry
Industry-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.25B
1.52B
939.39M
963.22M
Cost of goods sold
394.31M
337.79M
292.96M
182.86M
Cost of revenue
394.31M
337.79M
292.96M
182.86M
Research and development expenses
85.19M
29.81M
50.15M
44.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
696.15M
625.03M
371.90M
357.24M
Operating expense
807.49M
677.84M
441.00M
408.11M
Total operating expenses
1.20B
1.02B
733.96M
590.97M
Operating income
45.67M
499.57M
205.42M
372.24M
Other non operating income
1.48M
-450.84K
-152.55K
-19.27M
EBT including unusual items
-32.76M
494.29M
258.05M
308.23M
EBT excluding unusual items
66.32M
529.85M
223.56M
356.93M
Income tax expense
2.71M
71.23M
37.55M
39.06M
Effective tax rate
-8.27%
14.41%
14.55%
12.67%
Other operating expenses
28.38M
20.68M
14.35M
13.01M
Net income
-21.16M
423.80M
220.94M
272.08M
Net profit margin
-1.70%
27.97%
23.52%
28.25%
Earnings per share
-
-
-
-
Interest and investment income
22.29M
33.73M
20.96M
5.18M
Interest expense
-2.32M
-3.00M
-2.18M
-1.72M
Net interest expenses
19.97M
30.73M
18.79M
3.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
72.82M
526.71M
230.47M
399.39M
Gain or loss from assets sale
-2.83M
-
181.42K
-181.42K
Upcoming events
AI content may include mistakes. Learn more
Google apps